// App-Quantinova.ai

: Active Immune Thrombocytopenia (ITP) Disease Is Characterised By a Reduced Treg:CD8 Effector T Cell Ratio Which Is Modulated By Thrombopoietin-Receptor Agonists (TPO-RA)

Researchers

Presenter

  • Anwar A. Sayed

Principal Investigators

  • Amna Malik

  • Ahmad Khoder

  • George Adams

  • Nichola Cooper

Medical Centers

  • Centre for Haematology, Department of Medicine, Imperial College London, London, United Kingdom

  • Department of Medical Microbiology and Immunology, College of Medicine, Taibah University, Madinah, Saudi Arabia

Locations

  • United Kingdom

  • Saudi Arabia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Immune thrombocytopenia

Biomarkers

  • Peripheral blood mononuclear cell

  • Cluster of differentiation 8A

  • Interferon-gamma

  • Regulatory T cells

Drug/Treatment

  • Interferon Gamma

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A